140 related articles for article (PubMed ID: 14757156)
1. Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity.
Cao J; Wakatsuki A; Yoshida M; Kitazawa T; Taneike T
Eur J Pharmacol; 2004 Feb; 485(1-3):317-27. PubMed ID: 14757156
[TBL] [Abstract][Full Text] [Related]
2. Effects of the isoprostane, 8-epi-prostaglandin F2 alpha, on the contractility of the human myometrium in vitro.
Crankshaw D
Eur J Pharmacol; 1995 Oct; 285(2):151-8. PubMed ID: 8566133
[TBL] [Abstract][Full Text] [Related]
3. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
Dorn GW; Becker MW; Davis MG
J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
[TBL] [Abstract][Full Text] [Related]
5. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
6. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium.
Senior J; Sangha R; Baxter GS; Marshall K; Clayton JK
Br J Pharmacol; 1992 Sep; 107(1):215-21. PubMed ID: 1422574
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN
J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108
[TBL] [Abstract][Full Text] [Related]
9. Individual variations of prostanoid agonist responses in rabbit aorta: evidence for the independent regulation of prostanoid receptor subtypes.
Keith RA; Salama AI
Br J Pharmacol; 1987 Sep; 92(1):133-48. PubMed ID: 3664085
[TBL] [Abstract][Full Text] [Related]
10. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
Ogletree ML; Allen GT
J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
[TBL] [Abstract][Full Text] [Related]
11. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
12. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane receptor agonists enhance adrenergic neurotransmission in rabbit isolated mesenteric arteries.
Trachte GJ; Stein EA
J Pharmacol Exp Ther; 1989 Apr; 249(1):216-20. PubMed ID: 2540313
[TBL] [Abstract][Full Text] [Related]
15. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane binding and signal transduction in rat glomerular mesangial cells.
Spurney RF; Onorato JJ; Albers FJ; Coffman TM
Am J Physiol; 1993 Feb; 264(2 Pt 2):F292-9. PubMed ID: 8447439
[TBL] [Abstract][Full Text] [Related]
17. Intracellular Ca2+ elevation and contraction due to prostaglandin F2alpha in rat aorta.
Tosun M; Paul RJ; Rapoport RM
Eur J Pharmacol; 1997 Dec; 340(2-3):203-8. PubMed ID: 9537816
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells.
Hunt JA; Merritt JE; MacDermot J; Keen M
Biochem Pharmacol; 1992 Apr; 43(8):1747-52. PubMed ID: 1315543
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the prostanoid DP receptor in human myometrium.
Fernandes B; Crankshaw D
Eur J Pharmacol; 1995 Sep; 283(1-3):73-81. PubMed ID: 7498323
[TBL] [Abstract][Full Text] [Related]
20. EP 171: a high affinity thromboxane A2-mimetic, the actions of which are slowly reversed by receptor blockade.
Jones RL; Wilson NH; Lawrence RA
Br J Pharmacol; 1989 Apr; 96(4):875-87. PubMed ID: 2743082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]